Variant report

Variant	esv3400513
Chromosome Location	chr20:24449177-24451725
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:81)
CpG islands
(count:856)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:81 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr20:24449689-24449861	H1-hESC	embryonic stem cell:	n/a	n/a
2	CHD1	chr20:24450623-24450818	H1-hESC	embryonic stem cell:	n/a	n/a
3	CHD2	chr20:24449687-24449904	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD2	chr20:24450335-24450691	H1-hESC	embryonic stem cell:	n/a	n/a
5	CTBP2	chr20:24449619-24450490	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTBP2	chr20:24450695-24452117	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr20:24449286-24449377	MCF-7	breast:	n/a	chr20:24449345-24449358
8	CTCF	chr20:24449304-24449392	MCF-7	breast:	n/a	chr20:24449345-24449358
9	CTCF	chr20:24449660-24449810	MCF-7	breast:	n/a	chr20:24449751-24449759
10	CTCF	chr20:24449260-24449410	WERI-Rb-1	eye:	n/a	chr20:24449345-24449358
11	CTCF	chr20:24449302-24449341	MCF-7	breast:	n/a	n/a
12	EGR1	chr20:24449494-24449951	H1-hESC	embryonic stem cell:	n/a	chr20:24449800-24449810
13	EGR1	chr20:24450174-24450630	H1-hESC	embryonic stem cell:	n/a	n/a
14	ESR1	chr20:24450218-24450507	ECC-1	luminal epithelium:	n/a	chr20:24450370-24450387 chr20:24450369-24450386
15	ESR1	chr20:24450256-24450579	ECC-1	luminal epithelium:	n/a	chr20:24450370-24450387 chr20:24450369-24450386
16	ESR1	chr20:24450196-24450532	ECC-1	luminal epithelium:	n/a	chr20:24450370-24450387 chr20:24450369-24450386
17	ESR1	chr20:24450147-24450524	ECC-1	luminal epithelium:	n/a	chr20:24450370-24450387 chr20:24450369-24450386
18	ESR1	chr20:24450135-24450570	ECC-1	luminal epithelium:	n/a	chr20:24450370-24450387 chr20:24450369-24450386
19	ESR1	chr20:24450152-24450614	ECC-1	luminal epithelium:	n/a	chr20:24450370-24450387 chr20:24450369-24450386
20	ESR1	chr20:24449772-24450150	ECC-1	luminal epithelium:	n/a	n/a
21	FOSL1	chr20:24449506-24449961	H1-hESC	embryonic stem cell:	n/a	n/a
22	FOSL1	chr20:24449505-24449961	H1-hESC	embryonic stem cell:	n/a	n/a
23	HA-E2F1	chr20:24449757-24450826	MCF-7	breast:	n/a	chr20:24450791-24450805 chr20:24450609-24450621 chr20:24450124-24450134 chr20:24450539-24450549 chr20:24449801-24449810 chr20:24449964-24449973
24	HDAC2	chr20:24449680-24450015	H1-hESC	embryonic stem cell:	n/a	n/a
25	JUND	chr20:24450158-24450250	H1-hESC	embryonic stem cell:	n/a	n/a
26	JUND	chr20:24451601-24451654	H1-hESC	embryonic stem cell:	n/a	n/a
27	KAP1	chr20:24449559-24450130	HEK293	kidney:	n/a	n/a
28	MAFK	chr20:24449634-24449799	H1-hESC	embryonic stem cell:	n/a	n/a
29	MAX	chr20:24450420-24450738	ECC-1	luminal epithelium:	n/a	n/a
30	MAX	chr20:24450393-24450895	MCF-7	breast:	n/a	n/a
31	MAX	chr20:24451351-24451842	H1-hESC	embryonic stem cell:	n/a	n/a
32	MYC	chr20:24450465-24450560	MCF-7	breast:	n/a	n/a
33	MYC	chr20:24451665-24451691	MCF-7	breast:	n/a	n/a
34	MYC	chr20:24450196-24450264	MCF-7	breast:	n/a	n/a
35	NFIC	chr20:24451451-24451940	ECC-1	luminal epithelium:	n/a	n/a
36	POLR2A	chr20:24450795-24450796	MCF-7	breast:	n/a	n/a
37	POLR2A	chr20:24450478-24450521	MCF-7	breast:	n/a	n/a
38	POLR2A	chr20:24450458-24451699	H1-neurons	neurons:	n/a	n/a
39	POLR2A	chr20:24450455-24450606	A549	lung:	n/a	n/a
40	POLR2A	chr20:24449652-24449992	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr20:24451724-24451787	MCF-7	breast:	n/a	n/a
42	POLR2A	chr20:24451674-24451706	Gliobla	brain:	n/a	n/a
43	POLR2A	chr20:24450601-24450605	MCF-7	breast:	n/a	n/a
44	POLR2A	chr20:24450815-24450987	MCF-7	breast:	n/a	n/a
45	POLR2A	chr20:24449859-24449966	MCF-7	breast:	n/a	n/a
46	POLR2A	chr20:24450157-24450566	H1-hESC	embryonic stem cell:	n/a	n/a
47	POLR2A	chr20:24450241-24450555	Gliobla	brain:	n/a	n/a
48	POLR2A	chr20:24451720-24451722	Gliobla	brain:	n/a	n/a
49	POLR2A	chr20:24449971-24450008	MCF-7	breast:	n/a	n/a
50	POLR2A	chr20:24450059-24450571	MCF-7	breast:	n/a	n/a

(count:856 , 50 per page) page: 1 2 3 4 5 6 7 ... 18

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:24449916-24449966	HepG2	liver:	n/a
2	chr20:24451084-24451134	AG04450	lung:	fetal
3	chr20:24449916-24449966	HepG2	liver:	n/a
4	chr20:24451084-24451134	AG04450	lung:	fetal
5	chr20:24449668-24449718	HepG2	liver:	n/a
6	chr20:24449734-24449784	GM12891	blood:	n/a
7	chr20:24449916-24449966	IMR90	lung:	fetal
8	chr20:24449704-24449754	AoSMC	blood vessel:	n/a
9	chr20:24449804-24449854	SK-N-MC	brain:	n/a
10	chr20:24450361-24450411	NT2-D1	testis:	n/a
11	chr20:24450361-24450411	AoSMC	blood vessel:	n/a
12	chr20:24450698-24450748	GM12878	blood:	n/a
13	chr20:24449804-24449854	NHBE	bronchial:	n/a
14	chr20:24450698-24450748	AG09319	gingival:	n/a
15	chr20:24449734-24449784	Jurkat	blood:	n/a
16	chr20:24451518-24451568	HepG2	liver:	n/a
17	chr20:24449916-24449966	MCF-7	breast:	n/a
18	chr20:24449392-24449442	ovcar-3	ovarian:	n/a
19	chr20:24450353-24450403	CMK	blood:	n/a
20	chr20:24451084-24451134	SK-N-SH_RA	brain:	n/a
21	chr20:24449668-24449718	LNCaP	prostate:	n/a
22	chr20:24449804-24449854	CMK	blood:	n/a
23	chr20:24449804-24449854	HIPEpiC	eye:	n/a
24	chr20:24449804-24449854	H1-hESC	embryonic stem cell:	embryo
25	chr20:24449734-24449784	RPTEC	kidney:	n/a
26	chr20:24449865-24449915	HCT-116	colon:	n/a
27	chr20:24451428-24451478	PANC-1	pancreas:	n/a
28	chr20:24450353-24450403	SK-N-SH_RA	brain:	n/a
29	chr20:24451518-24451568	HIPEpiC	eye:	n/a
30	chr20:24449704-24449754	BE2_C	brain:	n/a
31	chr20:24451518-24451568	NT2-D1	testis:	n/a
32	chr20:24450361-24450411	HUVEC	blood vessel:	n/a
33	chr20:24451518-24451568	T-47D	breast:	n/a
34	chr20:24449392-24449442	GM12892	blood:	n/a
35	chr20:24449760-24449810	GM12878	blood:	n/a
36	chr20:24449865-24449915	Jurkat	blood:	n/a
37	chr20:24449704-24449754	NB4	blood:	n/a
38	chr20:24451084-24451134	LNCaP	prostate:	n/a
39	chr20:24449704-24449754	HCF	heart:	n/a
40	chr20:24449760-24449810	CMK	blood:	n/a
41	chr20:24450353-24450403	HEEpiC	esophagus:	n/a
42	chr20:24449865-24449915	HCM	heart:	n/a
43	chr20:24451084-24451134	AG09309	skin:	n/a
44	chr20:24451084-24451134	Jurkat	blood:	n/a
45	chr20:24450361-24450411	HCPEpiC	choroid plexus:	n/a
46	chr20:24449734-24449784	NB4	blood:	n/a
47	chr20:24450361-24450411	HepG2	liver:	n/a
48	chr20:24449760-24449810	NHBE	bronchial:	n/a
49	chr20:24450698-24450748	HIPEpiC	eye:	n/a
50	chr20:24449916-24449966	Hela-S3	cervix:	n/a

No data

Variant related genes	Relation type
SYNDIG1	TF binding region
SYNDIG1	CpG island

Extended variants
information (count: 97 )
Associated
traits (count: 57 )

Variant overlapped rSNPs/rCNVs (count:97 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs560525831	chr20:24449184-24449185	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs369666138	chr20:24449244-24449245	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs545891795	chr20:24449250-24449251	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs74711420	chr20:24449299-24449300	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs531753449	chr20:24449329-24449330	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs61548213	chr20:24449440-24449441	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs568686621	chr20:24449462-24449463	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs118129779	chr20:24449494-24449495	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs138345148	chr20:24449504-24449505	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs555021156	chr20:24449522-24449523	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs188861005	chr20:24449527-24449528	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs576623629	chr20:24449536-24449537	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs149215431	chr20:24449564-24449565	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs539542318	chr20:24449588-24449589	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs370410006	chr20:24449619-24449620	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs143468729	chr20:24449668-24449669	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs112089462	chr20:24449695-24449696	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs141989966	chr20:24449717-24449718	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs185438745	chr20:24449724-24449725	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs377691984	chr20:24449907-24449908	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs137863212	chr20:24449917-24449918	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs572287050	chr20:24449942-24449943	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs541310662	chr20:24449944-24449945	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs553927052	chr20:24449959-24449960	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs577125082	chr20:24449969-24449970	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs141687430	chr20:24450056-24450057	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs562612868	chr20:24450081-24450082	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs531669082	chr20:24450082-24450083	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs542051356	chr20:24450106-24450107	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs562297278	chr20:24450284-24450285	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs528021373	chr20:24450313-24450314	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs376197913	chr20:24450321-24450322	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs548023204	chr20:24450323-24450324	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs570361916	chr20:24450326-24450327	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs532941695	chr20:24450384-24450385	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs549929085	chr20:24450385-24450386	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs569788371	chr20:24450396-24450397	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs535506975	chr20:24450419-24450420	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs544440226	chr20:24450426-24450427	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs555280481	chr20:24450474-24450475	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs565818931	chr20:24450587-24450588	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs575371135	chr20:24450656-24450657	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs112835691	chr20:24450681-24450682	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs534654369	chr20:24450692-24450693	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs558020557	chr20:24450699-24450700	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs576857524	chr20:24450736-24450737	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs189648670	chr20:24450790-24450791	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs145959093	chr20:24450817-24450818	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs73341652	chr20:24450823-24450824	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs370866262	chr20:24450851-24450852	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:57)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Breast cancer	16608533	CNVD
Bladder cancer	21909424	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	17133270	CNVD
Thrombophilia	17576883	CNVD
Myelofibrosis	22110671	CNVD
Mental retardation	21062444	CNVD
Hepatocellular carcinoma	22174799	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Chordoma	18071362	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:311 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:24439600-24449200	Weak transcription	Gastric	stomach
2	chr20:24439800-24449800	Weak transcription	Right Atrium	heart
3	chr20:24444400-24449400	Weak transcription	Right Ventricle	heart
4	chr20:24446000-24449800	Weak transcription	Aorta	Aorta
5	chr20:24447000-24449200	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
6	chr20:24447000-24449400	Weak transcription	Fetal Brain Male	brain
7	chr20:24447000-24449600	Weak transcription	Left Ventricle	heart
8	chr20:24447200-24449400	Weak transcription	Brain Angular Gyrus	brain
9	chr20:24447400-24449400	Weak transcription	Brain Cingulate Gyrus	brain
10	chr20:24447400-24449600	Weak transcription	Brain Substantia Nigra	brain
11	chr20:24448000-24450000	Bivalent Enhancer	Fetal Thymus	thymus
12	chr20:24448200-24449400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
13	chr20:24448600-24449400	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
14	chr20:24448600-24449400	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
15	chr20:24448600-24449600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
16	chr20:24448600-24449600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
17	chr20:24448800-24449200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
18	chr20:24448800-24449200	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr20:24448800-24449400	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr20:24448800-24449600	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
21	chr20:24448800-24449600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
22	chr20:24449000-24449200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
23	chr20:24449000-24449200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
24	chr20:24449000-24449200	Enhancers	Brain Anterior Caudate	brain
25	chr20:24449000-24449400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
26	chr20:24449000-24449400	Flanking Bivalent TSS/Enh	H9 Cell Line	embryonic stem cell
27	chr20:24449000-24449400	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
28	chr20:24449000-24449400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
29	chr20:24449000-24449400	Enhancers	Fetal Brain Female	brain
30	chr20:24449000-24449600	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr20:24449000-24449600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
32	chr20:24449000-24449600	Enhancers	Brain Hippocampus Middle	brain
33	chr20:24449000-24449600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
34	chr20:24449000-24449800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
35	chr20:24449000-24449800	Flanking Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
36	chr20:24449000-24449800	Enhancers	Fetal Heart	heart
37	chr20:24449200-24449400	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
38	chr20:24449200-24449400	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr20:24449200-24449400	Bivalent Enhancer	Primary hematopoietic stem cells	blood
40	chr20:24449200-24449400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
41	chr20:24449200-24449400	Bivalent Enhancer	Brain Anterior Caudate	brain
42	chr20:24449200-24449400	Enhancers	Brain Inferior Temporal Lobe	brain
43	chr20:24449200-24449400	Bivalent Enhancer	Fetal Lung	lung
44	chr20:24449200-24449400	Bivalent Enhancer	Fetal Muscle Leg	muscle
45	chr20:24449200-24449400	Enhancers	Gastric	stomach
46	chr20:24449200-24449400	Bivalent Enhancer	A549	lung
47	chr20:24449200-24449600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
48	chr20:24449200-24449600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
49	chr20:24449200-24449600	Bivalent Enhancer	Fetal Stomach	stomach
50	chr20:24449200-24451200	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links